Trial intelligence / Profile preview

tissue plasminogen activator for acute ischemic stroke

IRCT201709049014N182Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Hamadan University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT201709049014N182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201709049014N182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call